Last reviewed · How we verify

NCT02988167: EA

Introducing and Evaluating Extubation Advisor

Completed Last updated 21 March 2019
What this trial tests

trial in Intubation in 121 participants. Completed in 26 October 2018.

Timeline
1 June 2017
Primary endpoint
26 October 2018
26 October 2018

Quick facts

Lead sponsorOttawa Hospital Research Institute
StatusCompleted
Study typeOBSERVATIONAL
Enrollment121
Start date1 June 2017
Primary completion26 October 2018
Estimated completion26 October 2018
Sites1 location across Canada

Conditions studied

Sponsor

Ottawa Hospital Research Institute

Who can join

18 and older, any sex, with Intubation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Knowing when to liberate critically ill patients from mechanical ventilation (i.e. extubation) is of great importance as both prolonged ventilation and failed extubation are associated with increased morbidity, mortality \& costs. The study objective is to improve the safety of extubation by harnessing hidden information contained in the patterns of variation of heart and respiratory rate measured over intervals-in-time.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Feasibility of implementing <i>Extubation Advisor</i>, a clinical decision support tool to improve extubation decision-making in the ICU: a mixed-methods observational study.
    Sarti AJ, Zheng K, Herry CL, Sutherland S, et al · · 2021 · cited 5× · PMID 34385234 · DOI 10.1136/bmjopen-2020-045674

Verify or expand the search:

Other recruiting trials for Intubation

Currently open trials in the same condition.

Other Ottawa Hospital Research Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02988167.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing